RELYPSA, INC. COMMON STOCK PURCHASE WARRANTRelypsa Inc • May 3rd, 2016 • Pharmaceutical preparations • New York
THIS IS TO CERTIFY that [HOLDER], a Delaware limited partnership, and its permitted transferees, successors and permitted assigns (the “Holder”), for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, is entitled to purchase from RELYPSA, INC., a Delaware corporation (the “Company”), at the price of $18.76 per share (the “Exercise Price”), at any time after the date hereof (the “Commencement Date”) and expiring on April 27, 2023 (the “Expiration Date”), [______] shares of the fully paid and non-assessable common stock, par value $0.001 per share (“Common Stock”), of the Company (as such number may be adjusted as provided herein). The [______] shares of Common Stock which may be purchased pursuant to this Warrant are referred to herein as the “Aggregate Number”. This common stock purchase warrant (this “Warrant”) is issued under and pursuant to that certain Credit Agreement by and among the Company, the Holder, as Administrative Agent, and the
